Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age
This study has been completed.
Study NCT00376779 Information provided by GlaxoSmithKline
First Received: September 14, 2006 Last Updated: April 30, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diphtheria
Tetanus
Pertussis
Hepatitis B
Poliomyelitis
Haemophilus Infection
Additional conditions recognized in this trial
Haemophilus Infections
Hepatitis
Infection
Whooping Cough
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Bordetella Infections
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Clostridium Infections
Corynebacterium Infections
Digestive System Diseases
DNA Virus Infections
Enterovirus Infections
Gram-Negative Bacterial Infections
Gram-Positive Bacterial Infections
Hepadnaviridae Infections
Hepatitis, Viral, Human
Liver Diseases
Motor Neuron Disease
Myelitis
Nervous System Diseases
Neuromuscular Diseases
Pasteurellaceae Infections
Picornaviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Spinal Cord Diseases
Virus Diseases
Interventions listed in this trial
Infanrix hexa Vaccine
Sponsors listed in this trial
GlaxoSmithKline
Back to top of Main Content
